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Abstract
Background: The Salmonella enterica BarA-SirA, the Erwinia carotovora ExpS-ExpA, the Vibrio
cholerae BarA-VarA and the Pseudomonas spp GacS-GacA all belong to the same orthologous family
of two-component systems as the Escherichia coli BarA-UvrY. In the first four species it has been
demonstrated that disruption of this two-component system leads to a clear reduction in virulence
of the bacteria. Our aim was to determine if the Escherichia coli BarA-UvrY two-component system
is connected with virulence using a monkey cystitis model.
Results: Cystitis was generated in Macaque fascularis monkeys by infecting the bladder with a 1:1
mixture of the uropathogenic Escherichia coli isolate DS17 and a derivative where the uvrY gene had
been disrupted with a kanamycin resistance gene. Urine was collected through bladder punctuation
at subsequent time intervals and the relative amount of uvrY mutant was determined. This showed
that inactivation of the UvrY response regulator leads to a reduced fitness. In similar competitions
in culture flasks with Luria Broth (LB) the uvrY mutant rather had a higher fitness than the wild type.
When the competitions were done in flasks with human urine the uvrY mutant initially had a lower
fitness. This was followed by a fluctuation in the level of mutant in the long-term culture, with a
pattern that was specific for the individual urines that were tested. Addition of LB to the different
urine competition cultures however clearly led to a consistently higher fitness of the uvrY mutant.
Conclusion:  This paper demonstrates that the BarA-UvrY two-component system is a
determinant for virulence in a monkey cystitis model. The observed competition profiles
strengthen our previous hypothesis that disruption of the BarA-UvrY two-component system
impairs the ability of the bacteria to switch between different carbon sources. The urine in the
bladder contains several different carbon sources and its composition changes over time. Inability
to efficiently switch between the carbon sources may thus provide an explanation to the reduced
fitness of the uvrY mutant in the cystitis model.
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Background
The rapid adjustment of bacteria to new conditions largely
relies on two-component systems (TCS). In the prototypic
model an environmental stimulus interacts with the N-
terminus of a sensor protein, leading to autophosphoryla-
tion of a specific histidine residue using ATP. The sensor
then acts as a kinase and transmits the phosphate group to
a conserved aspartate residue on a cognate response regu-
lator protein. This normally enables the regulator to con-
trol the transcription of a certain set of genes by sequence
specific DNA binding.
Sequencing of the Escherichia coli genome has identified
more than 30 TCS [1]. Four Escherichia coli sensor pro-
teins, ArcB, EvgS, TorS and BarA, have two extra domains,
D1 and H2, besides the H1 transmitter domain and are
thus denoted as 'tripartite' [2-6]. The Escherichia coli tripar-
tite sensor BarA (bacterial adaptive response) forms a TCS
with the UvrY response regulator protein [7,8]. UvrY pos-
itively controls expression of the noncoding csrB and csrC
RNAs [9-11], which bind the 6.8 kD CsrA protein and
thus prevent it from interfering with ribosome loading of
various target mRNAs [12]. The Csr (carbon storage regu-
lation) system has been shown to have a major impact on
regulation on carbon metabolism pathways [13]. Dele-
tion of the barA or uvrY genes in Escherichia coli, as a con-
sequence, has drastic effects on the ability of the bacteria
to successfully grow in a competition depending on the
carbon source of the medium [14]. Mutations in the Csr
system in Escherichia coli and Salmonella enterica also cause
other phenotypic effects, including changes in motility,
adhesion and biofilm formation [10,15-19].
Deletions of orthologous systems in other bacteria; BarA-
SirA in Salmonella enterica, ExpS-ExpA in Erwinia caro-
tovora, BarA-VarA in Vibrio cholerae and GacS-GacA in Pseu-
domonas spp, clearly diminishes virulence of the bacteria
[20,21]. The fact that this system is important for infec-
tions in a large spectrum of host organisms has also been
corroborated by work demonstrating the necessity of the
Pseudomonas  GacS-GacA system for infections in either
animals, nematodes, insects or plants [22]. The underly-
ing mechanism behind this effect on virulence is far from
clear. Several indirect effects have been reported, particu-
larly on the formation of secreted molecules implied in
the virulence of the bacteria [20], but the only verified
direct target genes are functional homologues to the csrB/
csrC regulatory RNAs as well as the genes encoding the
HilA and HilC transcriptional regulators in Salmonella
[10,23,24].
The nature of a physiological stimulus acting directly on
the sensor is still elusive. Bile and intestinal short fatty
acids have a clear effect on this two-component system in
Salmonella enterica [25,26], although it is unclear if these
effects are mediated via the sensor or not. Considering the
fact that the system is activated in bacterial monocultures,
we earlier proposed that a stimulus reflects the energy/
growth status of the cell [14].
Escherichia coli is the causative agent in more than 80% of
the uncomplicated human urinary tract infections [27].
Macaque fascularis monkeys express the digalactoside
receptors to which the P fimbriated uropathogenic
Escherichia coli strains bind and thus provide a suitable
animal model system to study a cystitis [27]. Here we
show that a mutant in the BarA-UvrY two-component sys-
tem is less fit in a competition in such a cystitis model. We
propose that this effect is at least partially mediated by a
reduced ability to adapt the carbon metabolism in
response to the varying carbon sources in urine.
Results & discussion
Monkey cystitis competition assay
Two female monkeys were inoculated in the bladder with
a 1:1 mixture of the DS17 wild type and the AKP168 uvrY
mutant. Urine samples were collected at day 2, 5, 7, 13
and 15 to determine the colony forming units (CFU) and
the relative number of wild type and mutant bacteria.
Both monkeys exhibited typical symptoms of an acute
cystitis as measured by bacteruria and an increased level of
leukocyte markers in the urine (Table 1). The infections
were cleared naturally by day 13 from both animals
(Table 1). Our analysis of the isolated samples clearly
showed that the uvrY mutant AKP168 was rapidly lost in
both monkeys, in comparison with the wild type DS17
(Figure 1A). On the fifth day of infection more than 95 %
of the isolated bacteria were wild type. We also observed
a similar take-over of the wild type strain in samples col-
lected from the vagina in these monkeys (Figure 1B). This
is expected, as urine continuously contaminates the
vagina. We were however unable to perform additional
infections as there were no more animals available for
such a study.
Table 1: Leukocyte markers and CFU
Day Leukocytesa CFU in urine (CFU/ml)
110-7b 40-6b 110-7b 40-6b
2 1–2 2–3 9.5 × 104 4.6 × 105
532 – 3 3 . 2  ×  1 0 5 2.7 × 105
71 – 2 1 5  ×  1 0 2 2.5 × 104
13 0–1 0–1 0 0
15 0 0 0 0
aPresence of leukocytes was determined by the ECUR-dip stick test 
(Boehringer-Mannheim). Color changes of grades 1, 2 and 3 
correspond to 10–25, approximately 75, and approximately 500 
granulocytes/ml, respectively.
bIdentification number for the individual monkeys.BMC Microbiology 2006, 6:27 http://www.biomedcentral.com/1471-2180/6/27
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The BarA-UvrY two-component system controls the 
carbon utilization in the cell
We recently showed that the ability of a uvrY mutant to
grow in a competition culture with the wild type depends
on the growth medium, such that the mutant has a higher
fitness than the wild type in gluconeogenic media, e.g. LB,
but a lower fitness than the wild type in glycolytic media.
These results led us to conclude that the BarA-UvrY TCS is
important for the bacteria to efficiently switch between
different carbon sources [14]. The switching ability is cru-
cial in a glycolytic medium, as long-term growth will
change the composition of the medium, with a gradual
accumulation of secondary metabolites (e.g. acetate).
Accumulated intermediates will in turn be metabolized
when the primary metabolites are exhausted. When all
carbon sources are depleted from the medium, lysed bac-
teria will be the only carbon source that can be used. The
major carbon source in such lysates is amino acids [28]. In
gluconeogenic media, based on amino acids or other
small metabolites fuelling directly into the Krebs cycle,
the composition of the medium will be relatively
unchanged in a long-term culture, including the stage
when amino acids from lysed bacteria will be the princi-
pal carbon source. Growth in such media is not directly
aided by the BarA-UvrY TCS and mutants where the sen-
sor or regulator has been disrupted are rather more fit
than the wild type [14]. In support of our hypothesis, the
BarA-UvrY TCS has been demonstrated to control tran-
scription of the csrB and csrC noncoding RNAs [9,11,29],
which via the CsrA protein regulate the expression of
genes involved in gluconeogenis and glycolysis by
inversely controlling the concentration of their mRNA at
the post-transcriptional level [13]. In the case of csrB,
UvrY has been proven to act directly on the csrB promoter
[9].
Growth of wild type and uvrY mutant strains in human 
urine
To test if the higher fitness of the wild type bacteria in the
monkey cystitis model could be due to their ability to effi-
ciently switch between different carbon sources present in
urine we cultivated the bacteria in sterile filtered urine.
The composition of urine varies between individual sam-
ples, but typically contains a mixture of amino acids, sug-
ars and fatty acids as carbon sources [30,31].
We first cultivated the DS17 and the AKP168 strains indi-
vidually in urine freshly collected from three human sub-
jects (U1, U2 & U3). The growth varied significantly
between the individual urines but there was no significant
difference in growth between the mutant and the wild
type in any of the three urines (Figure 2A). We subse-
quently allowed the DS17  wild type and the AKP168
mutant to compete in these three human urines. Each
competition culture was first split into two and the level
of mutant was followed in each culture. In all six urine
competitions the level of uvrY mutant decreased during
the two first days, but this was followed by an increase in
the level of uvrY mutant with a fluctuating pattern that
was specific for each urine (Figure 2B and 2C). As urine is
a complex medium consisting of a mixture of carbon
sources, the initial decrease in the relative level of uvrY
mutant may well be explained by its impaired ability to
efficiently switch between gluconeogenic and glycolytic
The uvrY deletion mutant is outcompeted in the monkey  bladder Figure 1
The uvrY deletion mutant is outcompeted in the 
monkey bladder. A 1:1 mixture of DS17 and AKP168 
mutant was inoculated into the bladder of 2 individual mon-
keys (110-7 and 40-6) at day 0. Urine samples and vaginal 
smears were collected (day 2, 5 & 7). The percentage of the 
AKP168 mutant was determined in A. urine and B. vaginal 
smears.BMC Microbiology 2006, 6:27 http://www.biomedcentral.com/1471-2180/6/27
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carbon sources. The competition profiles were markedly
different between the urines but the same in the parallel
cultures from the same urine (although with a slight time
shift in U3). Our premise that the initial composition of
the individual urine determines the competition profile
agrees well with this reproducibility. The observed fluctu-
ations after day 1–2 are thus unlikely to be explained by
random processes or by spontaneous mutations in either
the  AKP168  or the wild type strain creating a growth
advantage in stationary phase, GASP mutants [32,33].
From the results, it is more likely that each competition
profile is decided by the initial composition of each indi-
vidual urine. To exclude that the reduced fitness of the
uvrY mutants in the urine cultures was the result of addi-
tional weakening mutations, we demonstrated that
mutants taken at day 7 from the different urine competi-
tions could successfully outcompete the wild type strain
in a competition in LB (Figure 3A).
The increase in the level of mutant after the initial
decrease may be explained by the massive lysis of bacteria
after the entry into stationary phase. Lysis will provide an
environment with an excess of gluconeogenic carbon
sources, where it is known that a uvrY mutant has a growth
advantage [14].
We also repeated the competition in the same urines (U1,
U2 & U3) complemented with LB. In these competitions
Growth of individual strains and In vitro competition in human urine Figure 2
Growth of individual strains and In vitro competition in human urine. A. DS17 (filled diamonds) and AKP168 (squares) 
were grown separately in vitro in three different human urines (U1, U2 & U3). B. 1:1 mixture of DS17 and AKP168 mutant was 
grown in the three different human urines (U1, U2 & U3) and samples were taken at the indicated time points to determine 
the percentage of AKP168 mutant. C. The same competitions as in B. but plotted as CFU with DS17 depicted as filled diamonds 
and AKP168 as squares.BMC Microbiology 2006, 6:27 http://www.biomedcentral.com/1471-2180/6/27
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In vitro competition in human urine complemented with LB Figure 3
In vitro competition in human urine complemented with LB. A. Re-competition of uvrY mutants in LB. Three AKP168 
individual mutant clones were isolated at day seven from the urine competitions (U1, U2 & U3) and competed against wild type 
DS17 in LB. Samples were taken at the indicated time points to determine the percentage of AKP168 mutant. B. The same 
experiment as in Figure 2B but the urine was complemented with LB (see Materials & Methods).BMC Microbiology 2006, 6:27 http://www.biomedcentral.com/1471-2180/6/27
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where there is a constant excess of gluconeogenic carbon
sources in the medium, the uvrY mutant rapidly outcom-
peted the wild type (Figure 3B), similar to what is
observed in LB alone (Figure 3A). Thus, there seems to be
no dominant factor in urine that would explain the low-
ered fitness of the uvrY mutant.
Although our model system cannot mimic the exact con-
ditions in the bladder, such as the continuous addition of
fresh urine, the data suggest that a uvrY mutant has an
impaired ability to efficiently metabolize the different
nutrient components in the urine. This also emphasizes
that an optimal growth rate is critical for bacteria during
an infection. In analogy with our results, it is interesting
to note that long-term growth of Pseudomonas strains in
gluconeogenic media selects for strains with inactivating
mutations in the orthologous GacS-GacA system, unlike
when the same strains are tested in an infection model
(Arabidopsis) [34]. It would be interesting to test what role
the described metabolic switches plays in the other bacte-
rial species where it is known that the BarA-UvrY two-
component system family affects virulence.
We cannot exclude that other factors under the control of
this TCS contributes to the lowered fitness of the uvrY
mutant observed in the in vivo cystitis model. Earlier stud-
ies have demonstrated effects of the BarA-UvrY TCS and
the downstream Csr system on adhesion, aggregation and
biofilm formation [10,15-19], all of which may play a role
in the persistence of bacteria in the bladder in concert
with the ability to utilize and switch between glycolytic
and gluconeogenic carbon sources.
Conclusion
This paper demonstrates that the BarA-UvrY system is a
determinant for virulence in a monkey cystitis model.
Based on different competition profiles we propose that
the BarA-UvrY TCS is important for the bacteria to effi-
ciently switch between different carbon sources present in
urine. This would provide a plausible explanation to the
reduced fitness of the uvrY mutant in the cystitis model as
urine consists of several different carbon sources and as
the prevalent carbon sources will change over time. This
also agrees well with the observed higher fitness of the
uvrY  mutant in competitions in purely gluconeogenic
media as the uvrY mutant is predisposed for gluconeogen-
esis. In conclusion, the ability to grow quickly and benefit
from the available carbon and energy sources is crucial for
virulence. During infection there may be different carbon
sources available and we believe that the ability to know
when to metabolize them is in part conferred by the BarA-
UvrY two-component system.
Methods
Monkey cystitis competition model
Two adult female Macaque fascularis monkeys were
infected by inoculation of a bacterial suspension (1 ml of
108 bacteria/ml), containing equal amounts of DS17 wild
type and the isogenic uvrY mutant AKP168, into the blad-
der using a catheter (the bladder void volume is approxi-
mately 150 ml). The monkeys had not been exposed to
the DS17 strain earlier. Bacteria had been taken from fresh
colony forming agar (CFA) plates (10 g Casamino acids,
1.5 g yeast extract, 50 mg MgSO4, 5 mg MnCl, 15 g Bacto
agar per liter) and resuspended in phosphate buffered
saline (PBS). Inocula were directly analyzed on selective
plates to assure that the level of mutant was close to 50 %.
Samples from monkeys were collected by suprapubic
bladder aspiration, using a syringe with vacutainer, at the
time points indicated until two successive negative cul-
tures were obtained (day 13 and day 15; Table 1). The ani-
mals were then considered healthy and removed from the
study. At 20–30 min before bladder aspiration, monkeys
were hydrated with approximately 50 ml of lukewarm
saline administered subcutaneously in the neck for opti-
mal diuresis. All experiments were done under ketamine
and midazolam anesthesia. Vaginal smears were collected
with cotton swabs. No DS17 bacteria could be isolated
from the feces of the monkeys before or after the infec-
tion. Monkeys were kept in the animal facility at the Swed-
ish Institute for Infectious Disease Control (SMI) in 80 ×
70 × 170 cm (width, depth, and height) cages, two in
each, and were handled by professional personnel accord-
ing to SMI regulations. Experiments were pre-approved by
the local ethics committee in Stockholm.
In vitro growth of strains
In this work we employed the uropathogenic Escherichia
coli strain DS17 [35] and the AKP168 derivative [14], with
the uvrY gene disrupted by a kanamycin resistance cas-
sette. The AKP168 mutant exhibited no measurable differ-
ence in growth relative the parental DS17 strain in a range
of different media, as measured by optical density and
CFU [14].
Growth was normally conducted in a 20 ml volume in
100 ml Erlenmeyer glass flasks at 37°C in a shaker with
200 rpm. Urine collected from healthy human male
donors was centrifuged at 4000 rpm and sterile filtered
through a 0.45 μM CA-filter (Corning Inc., NY). Urine-LB
was prepared by mixing four parts of sterile filtered urine
with one part of 5 × LB (50 g Bacto tryptone, 25 g Bacto
yeast extract and 50 g NaCl per liter).
In growth curve experiments each strain was grown as an
over night culture in LB (10 g Bacto tryptone, 5 g Bacto
yeast extract, 10 NaCl per liter) started directly from a -
80°C vial), washed twice in PBS, inoculated 1:100 in 20BMC Microbiology 2006, 6:27 http://www.biomedcentral.com/1471-2180/6/27
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ml urine. 1 ml samples were withdrawn and the optical
density was measured at 600 nm at the indicated time
points with a spectrophotometer.
In competition experiments each strain was grown as an
over night culture in LB (started directly from a -80°C
vial), washed twice in PBS, inoculated 1:100 in urine,
urine-LB, or plain LB, and grown as an individual culture
to A600 = 0.15–0.30. Subsequently, cultures were mixed
1:1 to a 20 ml volume. Samples of 100 μl were withdrawn
at the indicated time intervals and subjected to appropri-
ate dilution in PBS. Dilutions were added to Luria-Bertani
plates, with or without kanamycin (10 μg/ml), together
with 5 to 6 glass beads (6 mm diameter) (Stern Walter Inc,
NY, USA). Plates were gently agitated for 20 seconds to
evenly spread the bacteria over the plate, after which the
beads were removed. The relative level of mutant was cal-
culated by dividing the number of colonies growing on
the selective plate with the number of colonies growing
on the non-selective plate.
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